BILLERICA, Mass., March 14, 2019 /PRNewswire/ — Bruker Corporation (Nasdaq: BRKR) today announced that it has acquired Arxspan LLC, a provider of cloud-based scientific software and workflow solutions, based in Southborough, Massachusetts. Arxspan is known for its line of cloud-based products for the management of research data under the Arxlab® brand. The company has a focus... Read more
Darmstadt, Germany, March 14, 2019 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a collaboration agreement with Iktos, for the use of its generative modelling artificial intelligence (AI) technology, in order to facilitate the rapid and cost-effective discovery and design of promising new compounds. “This agreement is another illustration of... Read more
March 14, 2019 MilliporeSigma’s global network of more than 80 CRISPR core partners promote ethical scientific exploration with genome editing via access to company’s network of experts Zhejiang University is first in China to use MilliporeSigma’s Arrayed CRISPR Library MilliporeSigma, a leading science and technology company, today announced a CRISPR core partnership with Zhejiang University... Read more
12 MAR 2019 | DARMSTADT, GERMANY Merck KGaA, Darmstadt, Germany, is convinced that the proposed Entegris acquisition is not the best option available for Versum shareholders Merck KGaA, Darmstadt, Germany’s all-cash $48 per share proposal clearly superior to Entegris acquisition Merck KGaA, Darmstadt, Germany, a leading science and technology company, today filed a preliminary proxy statement with the U.S.... Read more
NKI completes institute wide adoption of Labguru to increase efficiency and maximize productivity in the laboratory 12 March 2019, Cambridge, MA: BioData has announced The Netherlands Cancer Institute (NKI) has started an institute wide deployment of its flagship product Labguru. NKI has secured an institutional licence of Labguru’s Electronic Lab Notebook (ELN) for further collaboration across... Read more
San Diego, Calif. and Wilmington, Mass. – March 12, 2019 – Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research today announced a licensing agreement with Charles River Laboratories International, Inc.’s Research Models and Services business. The agreement, designed to expand access to... Read more
Chicago, IL and Logan, Utah, USA – 11 March 2019 — GE Healthcare announces a digital data exchange collaboration program with Amgen, which will include advanced data analytics to increase the understanding of the relationship between raw material variability and process performance during the manufacture of biologic medicines. As a part of this initiative, GE... Read more
Germantown, Maryland, Hilden, Germany, and Männedorf, Switzerland, March 08, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Tecan Group AG (SIX Swiss Exchange: TECN), a global leader in laboratory automation and liquid handling technology, announced today a collaboration to improve the processing of QIAGEN’s QuantiFERON-TB Gold Plus (QFT-Plus) diagnostic test through the... Read more
7 Mar Oxford Instruments Plasma Technology collaborate with EU partners to develop a new class of on-chip gas sensing technology within project ULISSES. The collaboration aims to develop a new class of miniaturized optical gas sensors on a chip, enabling low-cost distributed sensing nodes for the Internet of Things (IoT). Stockholm, Sweden – Feb. 20,... Read more
Basel, 07 March 2019 Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has commenced a cash tender offer for all of the outstanding shares of common stock of Spark Therapeutics, Inc. (NASDAQ: ONCE) at a price of US$ 114.50 per share. The tender offer is being made pursuant to the previously announced merger... Read more